These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21679922)

  • 1. [Usefulness of microalbuminuria in the metabolic syndrome as a predictor of cardiovascular disease. Prospective study about 78 cases].
    Bendriss L; Lebbaq A; Jallal H; Mrani S; Khatouri A
    Ann Cardiol Angeiol (Paris); 2012 Feb; 61(1):15-9. PubMed ID: 21679922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality.
    Klausen KP; Parving HH; Scharling H; Jensen JS
    J Intern Med; 2007 Oct; 262(4):470-8. PubMed ID: 17875184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microalbuminuria and the metabolic syndrome and its components in the Chinese population.
    Lin CC; Liu CS; Li TC; Chen CC; Li CI; Lin WY
    Eur J Clin Invest; 2007 Oct; 37(10):783-90. PubMed ID: 17888089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Microalbuminuria accounts for the increased vascular disease risk in diabetic patients with metabolic syndrome].
    Gimeno-Orna JA; Molinero-Herguedas E; Lou-Arnal LM; Boned-Juliani B; Labrador-Fuster T; Guiu-Campos M
    Rev Esp Cardiol; 2007 Nov; 60(11):1202-5. PubMed ID: 17996182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary PGDS levels are associated with vascular injury in type 2 diabetes patients.
    Yoshikawa R; Wada J; Seiki K; Matsuoka T; Miyamoto S; Takahashi K; Ota S; Taniai K; Hida K; Yamakado M; Shikata K; Uehara Y; Urade Y; Makino H
    Diabetes Res Clin Pract; 2007 Jun; 76(3):358-67. PubMed ID: 17007955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Microalbuminuria with Metabolic Syndrome among Aged Population.
    Li XH; Lin HY; Wang SH; Guan LY; Wang YB
    Biomed Res Int; 2016; 2016():9241278. PubMed ID: 27200378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do albuminuria and hs-CRP add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome?
    van der Velde M; Bello AK; Brantsma AH; El Nahas M; Bakker SJ; de Jong PE; Gansevoort RT
    Nephrol Dial Transplant; 2012 Jun; 27(6):2275-83. PubMed ID: 22231032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to abandon microalbuminuria?
    Ruggenenti P; Remuzzi G
    Kidney Int; 2006 Oct; 70(7):1214-22. PubMed ID: 16871239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does microalbuminuria predict cardiovascular events in nondiabetic men with treated hypertension? Risk Factor Intervention Study Group.
    Agewall S; Wikstrand J; Ljungman S; Herlitz H; Fagerberg B
    Am J Hypertens; 1995 Apr; 8(4 Pt 1):337-42. PubMed ID: 7619345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very low-grade albuminuria reflects susceptibility to chronic kidney disease in combination with cardiovascular risk factors.
    Heo NJ; Ahn JM; Lee TW; Chin HJ; Na KY; Chae DW; Kim S
    Hypertens Res; 2010 Jun; 33(6):573-8. PubMed ID: 20379188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary albumin excretion at follow-up predicts cardiovascular outcomes in subjects with resistant hypertension.
    Oliveras A; Armario P; Sierra C; Arroyo JA; Hernández-del-Rey R; Vazquez S; Larrousse M; Sans L; Roca-Cusachs A; de la Sierra A
    Am J Hypertens; 2013 Sep; 26(9):1148-54. PubMed ID: 23747954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events.
    Solbu MD; Kronborg J; Jenssen TG; Njølstad I; Løchen ML; Mathiesen EB; Wilsgaard T; Eriksen BO; Toft I
    Atherosclerosis; 2009 Jun; 204(2):503-8. PubMed ID: 19091314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential link of microalbuminuria with metabolic syndrome in patients undergoing coronary angiography.
    Anvari MS; Boroumand MA; Pourgholi L; Sheikhfathollahi M; Rouhzendeh M; Rabbani S; Goodarzynejad H
    Arch Med Res; 2009 Jul; 40(5):399-405. PubMed ID: 19766905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension.
    Salles GF; Cardoso CR; Fiszman R; Muxfeldt ES
    Atherosclerosis; 2011 May; 216(1):199-204. PubMed ID: 21315356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome is independently associated with microalbuminuria in type 2 diabetes.
    Esteghamati A; Rashidi A; Khalilzadeh O; Ashraf H; Abbasi M
    Acta Diabetol; 2010 Jun; 47(2):125-30. PubMed ID: 19479185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort.
    Enhörning S; Bankir L; Bouby N; Struck J; Hedblad B; Persson M; Morgenthaler NG; Nilsson PM; Melander O
    Int J Obes (Lond); 2013 Apr; 37(4):598-603. PubMed ID: 22614056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central blood pressure and pulse wave velocity: relationship to target organ damage and cardiovascular morbidity-mortality in diabetic patients or metabolic syndrome. An observational prospective study. LOD-DIABETES study protocol.
    Gómez-Marcos MA; Recio-Rodríguez JI; Rodríguez-Sánchez E; Castaño-Sánchez Y; de Cabo-Laso A; Sánchez-Salgado B; Rodríguez-Martín C; Castaño-Sánchez C; Gómez-Sánchez L; García-Ortiz L
    BMC Public Health; 2010 Mar; 10():143. PubMed ID: 20298558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.